Placebo Surgery in Trials of Therapy for Parkinson's Disease
- 3 February 2000
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 342 (5) , 353-355
- https://doi.org/10.1056/nejm200002033420512
Abstract
The Sounding Board articles by Freeman et al.1 and Macklin2 (Sept. 23 issue) provided an excellent discussion of sham surgery for patients with Parkinson's disease. However, Freeman et al. seem overenthusiastic about downplaying the risks of sham surgery. Their statement that these procedures are easier to perform, standardize, and reproduce than traditional surgical procedures does not do justice to the neurosurgical skills involved in performing stereotactic brain surgery. It is probable that the wide range of outcomes regarding the effectiveness of and morbidity associated with pallidotomy is related to the varying skills of the operating neurosurgeon.Keywords
This publication has 5 references indexed in Scilit:
- The Ethical Problems with Sham Surgery in Clinical ResearchNew England Journal of Medicine, 1999
- Use of Placebo Surgery in Controlled Trials of a Cellular-Based Therapy for Parkinson's DiseaseNew England Journal of Medicine, 1999
- Reflections on randomised controlled trials in surgeryThe Lancet, 1999
- New Fight Over Fetal Tissue GraftsScience, 1994
- The Use of Placebos in Randomized Clinical TrialsIRB: Ethics & Human Research, 1985